Royal Philips/$PHG
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Royal Philips
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.
Ticker
$PHG
Sector
Primary listing
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
67,247
ISIN
US5004723038
Website
Royal Philips Metrics
BasicAdvanced
$23B
51.88
$0.47
0.82
$0.82
3.35%
Price and volume
Market cap
$23B
Beta
0.82
52-week high
$31.83
52-week low
$20.77
Average daily volume
1.2M
Dividend rate
$0.82
Financial strength
Current ratio
1.283
Quick ratio
0.692
Long term debt to equity
60.164
Total debt to equity
64.538
Dividend payout ratio (TTM)
0.27%
Interest coverage (TTM)
6.29%
Profitability
EBITDA (TTM)
3,009.527
Gross margin (TTM)
43.42%
Net profit margin (TTM)
2.07%
Operating margin (TTM)
10.66%
Effective tax rate (TTM)
78.88%
Revenue per employee (TTM)
$318,280
Management effectiveness
Return on equity (TTM)
1.99%
Valuation
Price to earnings (TTM)
51.885
Price to revenue (TTM)
1.076
Price to book
1.64
Price to tangible book (TTM)
-15.03
Price to free cash flow (TTM)
144.426
Free cash flow yield (TTM)
0.69%
Free cash flow per share (TTM)
16.98%
Dividend yield (TTM)
3.35%
Forward dividend yield
3.35%
Growth
Revenue change (TTM)
-0.88%
Earnings per share change (TTM)
-146.18%
3-year revenue growth (CAGR)
1.40%
10-year revenue growth (CAGR)
-2.01%
3-year earnings per share growth (CAGR)
-50.56%
10-year earnings per share growth (CAGR)
0.60%
What the Analysts think about Royal Philips
Analyst ratings (Buy, Hold, Sell) for Royal Philips stock.
Bulls say / Bears say
Philips' Q3 2023 results showed an 11% sales growth and doubled profitability, leading to an improved full-year outlook. (investing.com)
The company is enhancing its product portfolio with AI-enabled innovations in MRI and ultrasound systems, aiming to improve patient outcomes and operational efficiency. (simplywall.st)
Philips has been recognized as the top-ranked medical technology company among Clarivate's Top 100 Global Innovators, reflecting its strong commitment to innovation. (simplywall.st)
Philips lowered its 2025 profit margin forecast due to the impact of tariffs from ongoing trade tensions, estimating a net impact of €250–€300 million. (reuters.com)
The company faced a significant recall of MRI machines due to explosion risks, with the FDA classifying it as a Class I event, indicating potential serious injuries or death. (yahoo.com)
Philips' Q3 2024 earnings missed expectations, with sales declining by 2% year-over-year, leading to a downward revision of its 2024 outlook. (benzinga.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.
Royal Philips Financial Performance
Revenues and expenses
Royal Philips Earnings Performance
Company profitability
Royal Philips News
AllArticlesVideos
Methodist Hospitals Selects Philips to Advance Neurovascular, Cardiology and Complex Interventional Radiology Services in Northwest Indiana
Business Wire·1 week ago
Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people
GlobeNewsWire·4 weeks ago
Philips announces exchange ratio for 2024 dividend
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Royal Philips stock?
Royal Philips (PHG) has a market cap of $23B as of July 04, 2025.
What is the P/E ratio for Royal Philips stock?
The price to earnings (P/E) ratio for Royal Philips (PHG) stock is 51.88 as of July 04, 2025.
Does Royal Philips stock pay dividends?
Yes, the Royal Philips (PHG) stock pays dividends to shareholders. As of July 04, 2025, the dividend rate is $0.8222 and the yield is 3.35%. Royal Philips has a payout ratio of 0.27% on a trailing twelve-month basis.
When is the next Royal Philips dividend payment date?
The next Royal Philips (PHG) dividend payment date is unconfirmed.
What is the beta indicator for Royal Philips?
Royal Philips (PHG) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.